1. Home
  2. PVLA vs TRVG Comparison

PVLA vs TRVG Comparison

Compare PVLA & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • TRVG
  • Stock Information
  • Founded
  • PVLA 2015
  • TRVG 2005
  • Country
  • PVLA United States
  • TRVG Germany
  • Employees
  • PVLA N/A
  • TRVG N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • PVLA Health Care
  • TRVG Technology
  • Exchange
  • PVLA Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • PVLA 285.2M
  • TRVG 278.1M
  • IPO Year
  • PVLA N/A
  • TRVG N/A
  • Fundamental
  • Price
  • PVLA $53.42
  • TRVG $3.24
  • Analyst Decision
  • PVLA Strong Buy
  • TRVG Buy
  • Analyst Count
  • PVLA 11
  • TRVG 4
  • Target Price
  • PVLA $56.64
  • TRVG $4.50
  • AVG Volume (30 Days)
  • PVLA 153.4K
  • TRVG 113.3K
  • Earning Date
  • PVLA 08-14-2025
  • TRVG 08-05-2025
  • Dividend Yield
  • PVLA N/A
  • TRVG N/A
  • EPS Growth
  • PVLA N/A
  • TRVG N/A
  • EPS
  • PVLA N/A
  • TRVG N/A
  • Revenue
  • PVLA N/A
  • TRVG $592,176,160.00
  • Revenue This Year
  • PVLA N/A
  • TRVG $17.31
  • Revenue Next Year
  • PVLA N/A
  • TRVG $10.27
  • P/E Ratio
  • PVLA N/A
  • TRVG N/A
  • Revenue Growth
  • PVLA N/A
  • TRVG 7.39
  • 52 Week Low
  • PVLA $11.17
  • TRVG $1.60
  • 52 Week High
  • PVLA $53.93
  • TRVG $5.83
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 85.86
  • TRVG 39.01
  • Support Level
  • PVLA $46.08
  • TRVG $3.15
  • Resistance Level
  • PVLA $50.22
  • TRVG $3.89
  • Average True Range (ATR)
  • PVLA 3.11
  • TRVG 0.25
  • MACD
  • PVLA 0.70
  • TRVG -0.05
  • Stochastic Oscillator
  • PVLA 97.00
  • TRVG 5.88

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

Share on Social Networks: